Driven by the pressing need for innovative muscle disease therapies, their goal is to translate the pioneering research of Prof. Spuler's muscle research team at the Max Delbrück Center and Charité in Berlin into clinical practice. Early on, the team gained support from the SPARK-BIH program and later from the BioInnovation Institute's Incubator Program in Copenhagen.
As the CEO of a novel biotech company, Verena is eager to talk about her experiences and insights.
The webinar will be hosted by SPARK-BIH.
Online via MS Teams | Please register here!
Registration to the webinar is required in advance. Please register no later than 5th November 2024.Please note that you will receive the MS Teams Meeting link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
